16:27 GMT +323 October 2019
Listen Live
    OxyContin pills are arranged for a photo at a pharmacy in Montpelier, Vt.

    US Drugmaker Purdue Pharma Offers $10Bln to Settle Opioid Lawsuits - Reports

    © AP Photo / Toby Talbot
    Get short URL

    WASHINGTON (Sputnik) - US pharmaceutical giant Purdue Pharma and its owners have offered authorities a proposal worth at least $10 billion to settle more than 2,000 lawsuits related to the opioid crisis, media reported.

    Purdue Pharma has been hit with thousands of lawsuits for its role in the opioid addiction crisis that has led to record level overdoes throughout the United States dating back to the late 1990s.

    According to the US National Health Institute, Purdue Pharma falsely claimed in advertisements and in statements to federal regulators that the company’s main product, an opioid painkiller known as OxyContin, was not addictive.

    The potential deal was part of confidential talks with Purdue's lawyers at a meeting in Cleveland on 20 August, NBC News reported on Tuesday, citing two people familiar with the matter.

    At least ten US state attorneys general and the plaintiffs’ attorneys were gathered at the meeting where David Sackler represented the Sackler family, the owner of Purdue Pharma, the report added.

    The drugmaker did not confirm the proposed settlement terms but in a statement said it was working with the states attorneys general and plaintiffs to resolve the matter, according to the report.


    US Opioid Epidemic: 'Johnson & Johnson Account for 1% of Drug Market' - Prof
    Could Europe Be at Risk of US-Like Opioid Crisis?
    How Dems Are Hindering Trump's Effort to Nip the Cause of the Opioid Crisis in the Bud
    Why Are Two Pharmaceutical Companies Based in Ireland Caught Up In US Opioid Crisis?
    United States, authorities, settlement, opioid crisis, Purdue Pharma
    Community standardsDiscussion
    Comment via FacebookComment via Sputnik